Seed VC · USA
Avoro Ventures
What they invest in
Avoro Capital is a global life sciences investment firm focused on supporting emerging biotechnology companies through identifying unique or mispriced investment opportunities and providing financial and intellectual support over the investment lifecycle, while being vigilant in assessing macro and company-specific risks.
Who they back
Business models
biotech_therapeutics
Customer segments
Enterprise
Geography
US, Europe
Recent investments
- Aadi Bioscience
- Acerta Pharma
- Adaptimmune
+ 3 more deals. Score your deck to see the full investment history.
The people who write checks
We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.
Why this firm matters for fundraising founders
Avoro Ventures writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Avoro Ventures alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
At a glance
- Based in
- United States
- Last known deal
- Apr 2022
- Website
- avorocapital.com ↗
Other firms investing in DeepTech
See all investors
Is Avoro Ventures the right fit for your deck?
Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Avoro Ventures is one of them, and we'll tell you exactly where they sit in your top 100.